Avoro Capital Advisors LLC Krystal Biotech, Inc. Transaction History
Avoro Capital Advisors LLC
- $7.33 Billion
- Q2 2024
A detailed history of Avoro Capital Advisors LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,433,000 shares of KRYS stock, worth $431 Million. This represents 6.1% of its overall portfolio holdings.
Number of Shares
2,433,000
Previous 2,555,555
4.8%
Holding current value
$431 Million
Previous $455 Million
1.74%
% of portfolio
6.1%
Previous 5.48%
Shares
10 transactions
Others Institutions Holding KRYS
# of Institutions
266Shares Held
25MCall Options Held
270KPut Options Held
172K-
Black Rock Inc. New York, NY3.95MShares$699 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$508 Million0.01% of portfolio
-
State Street Corp Boston, MA1.33MShares$236 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$181 Million12.22% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$175 Million10.7% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.55B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...